,,ii  #aaith ,,congress  #ast ,session  
,s4 #cebb  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,december #ag1 
#bjbe,ms4 ,hassan 7for herself and ,mr4 
,justice7 introduced the following bill2
 which was read twice and referred to   
the ,committee on ,finance  ,a ,,bill   
,to amend title ,,xix of the ,social    
,security ,act to require that ,state   
,medicaid programs provide at least one 
formulation of each type of medication  
for the treatment of opioid use disorder
 without prior authorization or         
limitations on dosage1 and for other    
purposes4  #a4 ,short title ,this ,act  
may be cited as the ,no ,red ,tape ,for 
,addiction ,treatment ,act4  #b4        
,provision of medication-assisted       
treatment for opioid use disorder       
without prior authorization or          
limitations on dosage under ,medicaid   
7a7 ,in general ,section #aije of the   
,social ,security ,act 7#db ,u4,s4,c4   
#acif;d7 is amended-- 7#a7 in subsection
 7a77#bi71 by striking 7#b7 and 7#c7 and

 inserting 7#b71 7#c71 and 7#d72 and    
7#b7 in subsection 7ee71 by adding at   
the end the following new paragraph3    
7#d7 ,provision of medication-assisted  
treatment without prior authorization   
7,a7 ,in general ,a ,state plan 7or a   
waiver of such plan7 shall provide      
coverage of at least #a formulation of  
each drug and biological product        
described in paragraph 7#a77;,a7 7which 
shall include1 if available with respect
 to such a drug or biological product1 a
 formulation that is long-lasting and   
injectable7 that is not subject to prior
 authorization or limitations on dosage 
as a condition of coverage or payment   
for such drug or biological product4    
7,b7 ,rule of construction ,the         
requirement under subparagraph 7,a7 to  
provide coverage of at least #a         
formulation of each drug and biological 
product described in paragraph 7#a77;,a7
 shall not be construed as modifying or 
limiting the ability of a ,state to     
establish a formulary that is consistent

 with the requirements of section       
#aibg7;d77#d74  4  7b7 ,conforming      
amendment ,section #aibg7;d77#a77;,a7 of
 the ,social ,security ,act 7#db        
,u4,s4,c4 #acifr-#h7;d77#a77;,a77 is    
amended by striking ,a ,state and       
inserting ,except as provided in section
 #aije7;ee77#d71 a ,state4  7c7         
,effective date  7#a7 ,in general       
,subject to paragraph 7#b71 the         
amendments made by this subsection shall
 apply with respect to medical          
assistance provided on or after the date
 that is #a year after the date of      
enactment of this ,act4  7#b7 ,exception
 for state legislation ,in the case of a
 ,state plan under title ,,xix of the   
,social ,security ,act 7#db ,u4,s4,c4   
#acif et seq47 that the ,secretary of   
,health and ,human ,services determines 
requires ,state legislation in order for
 such plan to meet any requirement      
imposed by the amendments made by this  
section1 such plan shall not be regarded
 as failing to comply with the          

requirements of such title solely on the
 basis of its failure to meet such an   
additional requirement before the first 
day of the first calendar quarter       
beginning after the close of the first  
regular session of the ,state           
legislature that begins after the date  
of the enactment of this ,act4 ,for     
purposes of the previous sentence1 in   
the case of a ,state that has a #b-year 
legislative session1 each year of the   
session shall be considered to be a     
separate regular session of the ,state  
legislature4  #c4 ,,macpac report on    
utilization of management controls on   
the treatment of opioid use disorder    
under ,medicaid ,not later than #a year 
after the date of enactment of this     
section1 the ,medicaid and ,,chip       
,payment and ,access ,commission shall  
submit to ,congress a report on issues  
related to utilization management       
controls for medication-assisted        
treatment of opioid use disorder under  
the ,medicaid program4 ,such report     

shall include-- 7#a7 an analysis and    
description of the use of utilization   
management controls for                 
medication-assisted treatment furnished 
through the ,medicaid program across all
 ,states 7as defined in section         
#aaja7;a77#a7 of the ,social ,security  
,act 7#db ,u4,s4,c4 #acja7;a77#a77 for  
purposes of title ,,xix of such ,act71  
including dosing restrictions1 age      
limits1 counseling requirements1 and    
psychological screening requirements2   
7#b7 an assessment of the extent to     
which such utilization management       
controls impose an administrative burden
 on clinicians and other providers2 and 
7#c7 an assessment of other ,medicaid   
policies1 at both the ,federal and      
,state level1 that impede patient access
 to medication-assisted treatment and   
complicate clinician or provider        
prescribing practices4